Comera Life Sciences Holdings, Inc.: Nasdaq/NYSE listing notice — Comera receives Nasdaq delisting notice for bid price below $1.00

Comera Life Sciences Holdings, Inc.

Nasdaq notified Comera on May 2, 2023 of non-compliance with minimum bid price of $1.00.
Company has 180 calendar days, until Oct 30, 2023, to regain compliance.
To cure, stock must close at or above $1.00 for 10 consecutive business days.
If not cured by Oct 30, Comera may seek an additional 180-day extension if it meets other listing standards.
Company is evaluating options but cannot assure compliance or continued listing.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Comera Life Sciences Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

May 2, 2023, Comera Life Sciences Holdings, Inc. (the “Company”) received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market, as set forth in Listing Rule 5550(a)(2). In accordance with Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days, or until October 30, 2023, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company’s common stock must meet or exceed $1.0

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-137076

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.